Sun Pharma Plunges After Report Suggests SEBI May Reopen Insider Trading Case
An employee cleans a sign outside the Sun Pharmaceutical Industries Ltd. (Photographer: Amit Madheshiya/Bloomberg)

Sun Pharma Plunges After Report Suggests SEBI May Reopen Insider Trading Case

Shares of Sun Pharma dropped as much as 10.4 percent, its biggest decline since May 2017, after news agency PTI reported quoting unnamed sources that the market regulator is likely to reopen an ins...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.